Xiaotian Zhu

This inventor holds 39 USPTO granted patents and 26 published patent applications, plus 6 CIPO patents and 12 EPO patents, primarily in Kinase Inhibitors. Top assignees: Ariad Pharmaceuticals, Inc., Amgen Inc., Genentech, Inc.. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaotian Zhu. Retrieved from https://idiyas.com/inventor/xiaotian-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 39 (Patent Applications = 26)

% Patents Active = 66.7

CIPO Patents = 6 (Patent Applications = 5)

EPO Patents = 12 (Patent Applications = 20)

Average Co-Inventor Count = 7.1

ph-index = 12

Forward Citations = 638(Granted Patents)

Location History:

Watertown, MA (US) (2003 - 2006)
Cambridge, MA (US) (2021 - 2023)
Newton, MA (US) (2005 - 2024)

Company Filing History:

22 out of 69

Ariad Pharmaceuticals, Inc.

Regor Pharmaceuticals, Inc.

patents

5. 1 out of 8

Qilu Regor Therapeutics Inc.

patents

6. 1 out of 1,229

Takeda Pharmaceutical Company Limited

patents

where one patent can have more than one assignee

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

HPK1 Inhibitors

c-Kit Inhibitors

EGFR Compounds

Protein Kinase Modulators

Aminothiazole Compounds

Anilinopyrimidines

Benzimidazole Compounds

Heteroaryl Compounds

Acetylenic Compounds

Phosphorus Derivatives

Furanopyrimidines

Pyrazolo Compounds

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12751951 - CDK inhibitors (2026-10-06),

2. 12740984 - CDK inhibitors (2026-09-22),

3. 12740983 - CDK inhibitors (2026-09-22),

4. 12708623 - CDK INHIBITORS (2026-08-18),

5. 12617811 - HPK1 inhibitors and uses thereof (2026-05-05),

6. 12612424 - HPK1 inhibitors and uses thereof (2026-04-28),

7. 12285429 - CDK inhibitors (2025-04-29),

8. 11958850 - Heteroaryl compounds for kinase inhibition (2024-04-16),

9. 11753404 - Aminothiazole compounds as c-Kit inhibitors (2023-09-12),

10. 11180482 - Anilinopyrimidines as haematopoietic progenitor kinase 1 (HPK1) inhibitors (2021-11-23),

11. 11117883 - Benzimidazole compounds as c-Kit inhibitors (2021-09-14),

12. 11001580 - Aminothiazole compounds as c-Kit inhibitors (2021-05-11),

13. 10227342 - Heteroaryl compounds for kinase inhibition (2019-03-12),

14. 9834571 - Compounds for inhibiting cell proliferation in EGFR-driven cancers (2017-12-05),

15. 9834521 - Choline kinase inhibitors (2017-12-05),

Title: Xiaotian Zhu - Innovative Inventor from Newton, MA

Introduction: Xiaotian Zhu is a visionary inventor based in Newton, MA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Xiaotian Zhu holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Xiaotian Zhu has worked with leading research institutions and tech companies, consistently pushing the boundaries of innovation.

Collaborations: Zhu has collaborated with top universities and multinational corporations, fostering a culture of innovation and knowledge-sharing in the industry.

Conclusion: Xiaotian Zhu's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs worldwide.

Profile summary based on public USPTO records.